Where I see patients (1)
My reviews
Selected research
- 
							Model based assessment of food and acid reducing agent effects on oral absorption of mezigdomide (CC-92480), a novel cereblon E3 ligase modulator.
							CPT: pharmacometrics & systems pharmacology
 - 
							Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
							The New England journal of medicine
 - 
							Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma.
							EJHaem
 
					
				
														
														
														
														
														
				
					
				
4.9